Thomas Michael Perone
General Counsel, Ovid Therapeutics Inc.
Companies
- Ovid Therapeutics Inc.General counsel Mar 26, 2019 to Feb 26, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Ovid Therapeutics Inc. OVID28,125 shares2$63.6K at $2.26Feb 22, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 22, 2024Granted 28,125 shares of Ovid Therapeutics Inc.2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2